U.S. President Donald Trump expressed confidence on Wednesday that China will soon impose the death penalty for fentanyl manufacturing and trafficking, signaling renewed optimism for a bilateral crackdown on the opioid crisis. Speaking ahead of signing the HALT Fentanyl Act, Trump emphasized collaboration with Beijing to halt the flow of synthetic opioids, which have claimed over 450,000 American lives in the past decade.
Fentanyl, a powerful synthetic opioid, remains a top cause of overdose deaths in the U.S., and Washington continues to pressure Beijing to tighten control over precursor chemicals exported from China. Trump’s remarks follow a series of recent moves aimed at reining in the deadly drug trade, including the February imposition of 20% tariffs on Chinese goods linked to fentanyl-related issues.
“I think China’s going to go from doing nothing to issuing the death penalty for those producing fentanyl and sending it here,” Trump told reporters. He added that talks with Chinese leader Xi Jinping were progressing and that Beijing was taking “big steps” in response.
In recent weeks, China has added two more fentanyl precursors—4-piperidone and 1-boc-4-piperidone—to its list of controlled substances. Authorities have also ramped up enforcement, seizing over 2 tons of drugs and arresting 262 individuals for trafficking. Over 1,300 prosecutions and 700 arrests for drug-related money laundering have been reported this year, showing a 2.1% increase from last year.
China, however, has pushed back on U.S. demands to publicize its efforts prominently and has accused Washington of politicizing the fentanyl issue. Still, Trump’s latest remarks suggest a possible breakthrough in cooperation as both nations grapple with rising overdose deaths and escalating tensions.


US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
New Zealand MMP Electoral System Faces Fresh Referendum Debate
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Myanmar Rejects ASEAN Special Envoy, Challenges Regional Peace Plan
US Supreme Court Lets $655.5 Million Judgment Against Palestinian Authorities Stand During Appeal
Brazil Rejects Visas for Trump Officials Ahead of Presidential Election
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
Houthi Attack on Yemen’s Mocha Port Kills Seven, Injures 30
Trump Administration to Ban Chinese Robots, Power Inverters Over AI Security Concerns
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Iran-Oman Near Strait of Hormuz Deal as Shipping Tensions Persist
France Keeps Top Health Alert as Officials Brace for Another Heatwave
China Vows Retaliation Over U.S. Ban on Chinese Robots, Power Inverters
AI Data Center Boom Faces New Risks as Public Backlash and Policy Scrutiny Grow
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 



